Company intelligence / Profile preview

Liaoning Haisco Pharmaceutical Co., Ltd.

Xingcheng, Liaoning, Chinaen.haisco.com ↗

Ownership: Private
Development stage: Commercial

Overview

Liaoning Haisco Pharmaceutical has a broad portfolio with 39 drug production approvals for 28 varieties as of December 2020. It has achieved first-in-China approvals for certain infusion products and commercializes drugs across several therapeutic areas including anti-infectives and parenteral nutrition. Notable clinical assets include arginine glutamate for hyperammonemia (approved) and dolasetron mesylate for vomiting/nausea (approved). The company also develops innovative anesthetics such as ciprofol.

Therapeutic areas: GastroenterologyHematologyNeurologyInfectious Diseases
Modalities: Small molecules (primary)lyophilized powdersinjections (small and large volume)pre-filled syringescephalosporins
Industry: Biotech

Drug pipeline

3 assets

nalmefene hydrochloride

Commercial

Indications: Pain management

2 more assets in the full pipeline.

Request access →

Beyond the preview

Go deeper on Liaoning Haisco Pharmaceutical Co., Ltd..

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Liaoning Haisco Pharmaceutical Co., Ltd..

Explore the full profile